Long intergenic non-protein coding RNA 1566 (LINC01566)

Long intergenic non-protein coding RNA 1566 (LINC01566) is a human long non-coding RNA (lncRNA), more specifically classified as a long intergenic non-coding RNA (lincRNA)[1][3][5]. LINC01566 is transcribed as an RNA molecule longer than 200 nucleotides that does not overlap with protein-coding genes and does not code for any protein product[1][3][5]. Functionally, while the large family of lincRNAs—including LINC01566—are thought to regulate gene expression, chromatin state, and genome architecture, specific roles for LINC01566 remain poorly characterized[1][3][5]. A recent report suggests it may participate in immune modulation, specifically negatively regulating CD4+ T cell activation and contributing to the pathogenesis of myasthenia gravis, an autoimmune disease[6]. However, there is no documentation of direct drug interactions, use as a biomarker, or established therapeutic targeting for this lincRNA[1][3][6].

Other names

LINC01566

Not applicable; no direct drug targeting known